Show simple item record

dc.contributor.authorSuskiewicz, MJ
dc.contributor.authorProkhorova, E
dc.contributor.authorRack, JGM
dc.contributor.authorAhel, I
dc.date.accessioned2024-07-18T10:52:02Z
dc.date.issued2023-10-12
dc.date.updated2024-07-17T09:52:00Z
dc.description.abstractADP-ribosylation is a ubiquitous modification of biomolecules, including proteins and nucleic acids, that regulates various cellular functions in all kingdoms of life. The recent emergence of new technologies to study ADP-ribosylation has reshaped our understanding of the molecular mechanisms that govern the establishment, removal, and recognition of this modification, as well as its impact on cellular and organismal function. These advances have also revealed the intricate involvement of ADP-ribosylation in human physiology and pathology and the enormous potential that their manipulation holds for therapy. In this review, we present the state-of-the-art findings covering the work in structural biology, biochemistry, cell biology, and clinical aspects of ADP-ribosylation.en_GB
dc.description.sponsorshipMedical Research Council (MRC)en_GB
dc.description.sponsorshipMedical Research Council (MRC)en_GB
dc.description.sponsorshipWellcome Trusten_GB
dc.description.sponsorshipWellcome Trusten_GB
dc.description.sponsorshipOxford University Challenge Seed Funden_GB
dc.description.sponsorshipBiotechnology and Biological Sciences Research Council (BBSRC)en_GB
dc.description.sponsorshipOvarian Cancer Research Allianceen_GB
dc.description.sponsorshipEuropean Research Councilen_GB
dc.description.sponsorshipLigue contre le Canceren_GB
dc.description.sponsorshipFrench National Centre for Scientific Research (CNRS)en_GB
dc.description.sponsorshipNational Institute for Health Researchen_GB
dc.format.extent4475-4495
dc.format.mediumPrint
dc.identifier.citationVol. 186, No. 21, pp. 4475-4495en_GB
dc.identifier.doihttps://doi.org/10.1016/j.cell.2023.08.030
dc.identifier.grantnumberMR/N006364/2en_GB
dc.identifier.grantnumberMR/V033417/1en_GB
dc.identifier.grantnumber210634en_GB
dc.identifier.grantnumber223107en_GB
dc.identifier.grantnumberUSCF 456en_GB
dc.identifier.grantnumberBB/R007195/1en_GB
dc.identifier.grantnumber813369en_GB
dc.identifier.grantnumber101078837en_GB
dc.identifier.grantnumberCSIRGO 2022en_GB
dc.identifier.urihttp://hdl.handle.net/10871/136759
dc.identifierORCID: 0000-0001-8341-6439 (Rack, Johannes GM)
dc.identifierScopusID: 56715439800 (Rack, Johannes GM)
dc.language.isoenen_GB
dc.publisherElsevieren_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/37832523en_GB
dc.rights© 2023 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).en_GB
dc.titleADP-ribosylation from molecular mechanisms to therapeutic implications.en_GB
dc.typeArticleen_GB
dc.date.available2024-07-18T10:52:02Z
dc.identifier.issn0092-8674
exeter.place-of-publicationUnited States
dc.descriptionThis is the final version. Available from Elsevier via the DOI in this record. en_GB
dc.identifier.eissn1097-4172
dc.identifier.journalCellen_GB
dc.relation.ispartofCell, 186(21)
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2023-08-23
dc.rights.licenseCC BY
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2023-10-12
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2024-07-18T10:42:28Z
refterms.versionFCDVoR
refterms.dateFOA2024-07-18T10:52:09Z
refterms.panelAen_GB
refterms.dateFirstOnline2023-10-12


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2023 The Author(s). Published by Elsevier Inc. 
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Except where otherwise noted, this item's licence is described as © 2023 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).